Pekin Hardy Strauss’s AstraZeneca AZN Stock Holding History

Pekin Hardy Strauss’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$610K	Sell	3,262 -200	-6%	-$37.6K	0.05%	285
2026 Q1	$671K	Sell	3,462 -180	-5%	-$34.7K	0.07%	262
2025 Q4	$670K	Buy	3,642 +1,817	+100%	+$319K	0.06%	246
2025 Q3	$280K	Hold	1,825	–	–	0.03%	343
2025 Q2	$255K	Buy	1,825 +74	+4%	+$10.4K	0.03%	313
2025 Q1	$257K	Sell	1,751 -1,149	-40%	-$166K	0.03%	301
2024 Q4	$380K	Buy	+2,900	New	+$406K	0.05%	275

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pekin Hardy Strauss's AZN Position: Q2 2026 in Review

Pekin Hardy Strauss reduced its AstraZeneca (AZN) stake by 5.8% in Q2 2026, selling an estimated $37.6K and leaving 3,262 shares worth $610K. The position accounts for 0.05% of the portfolio, ranked #285.

Pekin Hardy Strauss first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $671K in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Pekin Hardy Strauss held 3,262 shares of AstraZeneca worth $610K as of Q2 2026.
Pekin Hardy Strauss sold 200 AstraZeneca shares in Q2 2026, an estimated $37.6K.
AstraZeneca made up 0.05% of Pekin Hardy Strauss's portfolio in Q2 2026, its #285 holding.
Pekin Hardy Strauss first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
Pekin Hardy Strauss's AstraZeneca position peaked at $671K in Q1 2026.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.